-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$6.11 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
Neumora Therapeutics, Inc. Common Stock Insider Transactions
Neumora Therapeutics, Inc. Common Stock Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Burow Kristina
Director, 10 percent owner: |
Buy | 3,357 @ $11.98 | $40,217 | 4,131,207 | 11/14/2023 | 11/15/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 3,357 @ $11.98 | $40,217 | 4,131,207 | 11/14/2023 | 11/15/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 31,653 @ $11.75 | $371,923 | 4,127,850 | 11/13/2023 | 11/15/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 31,653 @ $11.75 | $371,923 | 4,127,850 | 11/13/2023 | 11/15/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 5,431 @ $11.75 | $63,814 | 4,096,197 | 11/10/2023 | 11/13/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 11,844 @ $11.37 | $134,666 | 4,090,766 | 11/10/2023 | 11/13/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 5,431 @ $11.75 | $63,814 | 4,096,197 | 11/10/2023 | 11/13/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 11,844 @ $11.37 | $134,666 | 4,090,766 | 11/10/2023 | 11/13/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 31,079 @ $10.53 | $327,262 | 4,078,922 | 11/09/2023 | 11/13/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 31,079 @ $10.53 | $327,262 | 4,078,922 | 11/09/2023 | 11/13/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 23,124 @ $11.79 | $272,632 | 4,047,843 | 11/08/2023 | 11/13/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 69,127 @ $10.78 | $745,189 | 4,024,719 | 11/08/2023 | 11/13/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 23,124 @ $11.79 | $272,632 | 4,047,843 | 11/08/2023 | 11/13/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 69,127 @ $10.78 | $745,189 | 4,024,719 | 11/08/2023 | 11/13/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 30,192 @ $11.50 | $347,208 | 3,955,592 | 11/07/2023 | 11/07/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 30,192 @ $11.50 | $347,208 | 3,955,592 | 11/07/2023 | 11/07/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 43,082 @ $11.55 | $497,597 | 3,925,400 | 11/06/2023 | 11/07/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 43,082 @ $11.55 | $497,597 | 3,925,400 | 11/06/2023 | 11/07/2023 | |
Burow Kristina
Director, 10 percent owner: |
Buy | 22,420 @ $11.38 | $255,140 | 3,882,318 | 11/03/2023 | 11/07/2023 | |
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 22,420 @ $11.38 | $255,140 | 3,882,318 | 11/03/2023 | 11/07/2023 |
Neumora Therapeutics, Inc. Common Stock Frequently Asked Questions
-
Who is on Neumora Therapeutics, Inc. Common Stock's Insider Roster?
The list of insiders at Neumora Therapeutics, Inc. Common Stock includes ARCH Venture Partners XII, LLC, Burow Kristina.
-
How much insider buying is happening at Neumora Therapeutics, Inc. Common Stock?
Insiders have purchased a total of 542,618 Neumora Therapeutics, Inc. Common Stock shares in the last 12 months for a total of 6.11 M sold.
-
Which Neumora Therapeutics, Inc. Common Stock insiders have been buying company stock?
The following insiders have purchased Neumora Therapeutics, Inc. Common Stock shares in the last 12 months: ARCH Venture Partners XII, LLC ($3.06 M), Burow Kristina ($3.06 M),